ATE407111T1 - Isolierte atomoxetinverunreinigung, verfahren zur herstellung von atomoxetinverunreinigungen und deren verwendung als referenzstandards - Google Patents

Isolierte atomoxetinverunreinigung, verfahren zur herstellung von atomoxetinverunreinigungen und deren verwendung als referenzstandards

Info

Publication number
ATE407111T1
ATE407111T1 AT05771573T AT05771573T ATE407111T1 AT E407111 T1 ATE407111 T1 AT E407111T1 AT 05771573 T AT05771573 T AT 05771573T AT 05771573 T AT05771573 T AT 05771573T AT E407111 T1 ATE407111 T1 AT E407111T1
Authority
AT
Austria
Prior art keywords
atomoxetine
impurities
isolated
producing
reference standards
Prior art date
Application number
AT05771573T
Other languages
English (en)
Inventor
Eugenio Castelli
Alessandra Vailati
Original Assignee
Teva Pharm Fine Chemicals Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharm Fine Chemicals Srl filed Critical Teva Pharm Fine Chemicals Srl
Application granted granted Critical
Publication of ATE407111T1 publication Critical patent/ATE407111T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/16—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring not being further substituted
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/06—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton from hydroxy amines by reactions involving the etherification or esterification of hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/48—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
AT05771573T 2004-06-28 2005-06-28 Isolierte atomoxetinverunreinigung, verfahren zur herstellung von atomoxetinverunreinigungen und deren verwendung als referenzstandards ATE407111T1 (de)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US58364104P 2004-06-28 2004-06-28
US58364404P 2004-06-28 2004-06-28
US58364304P 2004-06-28 2004-06-28
US60971604P 2004-09-14 2004-09-14
US62206504P 2004-10-25 2004-10-25
US65233105P 2005-02-11 2005-02-11
US65233205P 2005-02-11 2005-02-11
US65233005P 2005-02-11 2005-02-11
US66666605P 2005-03-30 2005-03-30
US67536905P 2005-04-26 2005-04-26
US68977805P 2005-06-09 2005-06-09
US69073805P 2005-06-14 2005-06-14

Publications (1)

Publication Number Publication Date
ATE407111T1 true ATE407111T1 (de) 2008-09-15

Family

ID=35783354

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05771573T ATE407111T1 (de) 2004-06-28 2005-06-28 Isolierte atomoxetinverunreinigung, verfahren zur herstellung von atomoxetinverunreinigungen und deren verwendung als referenzstandards

Country Status (11)

Country Link
US (5) US7378553B2 (de)
EP (4) EP1687254A2 (de)
JP (1) JP2008504302A (de)
KR (2) KR20070057703A (de)
AT (1) ATE407111T1 (de)
CA (5) CA2560899A1 (de)
DK (1) DK1761478T3 (de)
ES (1) ES2313387T3 (de)
IL (5) IL180357A0 (de)
PL (1) PL1761478T3 (de)
WO (5) WO2006068662A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1687254A2 (de) 2004-06-28 2006-08-09 Teva Pharmaceutical Fine Chemicals S.R.L. Verfahren zur optischen trennung und rückgewinnung von tomoxetin
US7439399B2 (en) * 2004-06-28 2008-10-21 Teva Pharmaceutical Fine Chemicals Processes for the preparation of atomoxetine hydrochloride
EP1768949A2 (de) 2004-07-22 2007-04-04 Teva Pharmaceutical Fine Chemicals S.R.L. Polymorphe von atomoxetien-hydrochlorid
US20080004470A1 (en) * 2004-09-27 2008-01-03 Mathad Vijayavitthal T Synthesis of Atomoxetine Hydrochloride
JP2008501721A (ja) * 2005-04-05 2008-01-24 テバ ファーマシューティカル ファイン ケミカルズ ソチエタ レスポンサビリタ リミテ 安定性アトモキセチン塩酸塩、その調製方法及びその安定性の分析的調節
US8515185B2 (en) * 2009-11-25 2013-08-20 Google Inc. On-screen guideline-based selective text recognition
WO2011161690A1 (en) * 2010-06-23 2011-12-29 Symed Labs Limited Processes for the preparation of (+)-n,n-dimethyl-2-[1-(naphthalenyloxy) ethyl] benzene methanamine and intermediates thereof
US9604906B2 (en) * 2013-07-02 2017-03-28 Zcl Chemicals Limited Process for the preparation of 3-aryloxy-3-phenylpropylamine and salt thereof
CN104628768A (zh) * 2015-03-06 2015-05-20 江苏正大清江制药有限公司 一种伊班膦酸钠的制备方法
CN108929236A (zh) * 2017-05-26 2018-12-04 万特制药(海南)有限公司 盐酸托莫西汀的制备
CN110194719B (zh) * 2019-06-12 2020-05-15 山东大学 一种r-(-)-盐酸阿托莫西汀的制备方法
CN113336654B (zh) * 2020-02-18 2022-12-09 上海医药工业研究院 一种n-甲基-3-(2-甲基苯氧基)***的制备方法
CN113358773B (zh) * 2021-05-21 2022-09-13 健民药业集团股份有限公司 一种检测盐酸托莫西汀对映异构体的反相液相色谱方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4194009A (en) * 1974-01-10 1980-03-18 Eli Lilly And Company Aryloxyphenylpropylamines for obtaining a psychotropic effect
US4018895A (en) 1974-01-10 1977-04-19 Eli Lilly And Company Aryloxyphenylpropylamines in treating depression
FI77018C (fi) * 1980-11-14 1989-01-10 Lilly Co Eli Analogifoerfarande foer framstaellning av antidepressivt aktiv (-)-enantiomer av n-metyl-n-/3-(2-metylfenoxi) -3-fenylpropyl/amin och dess farmaceutiskt godtagbara salt.
US4777291A (en) 1985-02-27 1988-10-11 Eli Lilly And Company Racemization process
DK630987D0 (da) * 1987-12-01 1987-12-01 Ferrosan As Aryloxyphenylpropylaminer, deres fremstilling og anvendelse
US4868344A (en) * 1988-03-30 1989-09-19 Aldrich-Boranes, Inc. Novel process of producing phenyl or substituted phenylalkylamine pharmaceutical agents and novel chiral intermediates of high enantiomeric purity useful therein
DE4123253A1 (de) 1991-07-15 1993-01-21 Schneider Manfred Prof Dr Verfahren zur enzymatischen racematspaltung halogenierter arylalkanole
HU9202128D0 (en) 1992-06-26 1992-10-28 Richter Gedeon Vegyeszet Method for producing n-methyl-(3-phenyl-3-(4-[trifluoro-methyl])-phenooxi-)-amine
US5658590A (en) * 1995-01-11 1997-08-19 Eli Lilly And Company Treatment of attention-deficit/hyperactivity disorder
GB9812413D0 (en) 1998-06-10 1998-08-05 Glaxo Group Ltd Compound and its use
AU3219800A (en) 1999-03-29 2000-10-16 Eli Lilly And Company Stereospecific method for preparing tomoxetine and intermediates thereof
EP1171417B1 (de) * 1999-04-09 2005-11-09 Eli Lilly And Company Verfahren zur herstellung von 3-aryloxy-3-arylpropylamine und deren zwischenprodukte
WO2000064855A1 (en) 1999-04-26 2000-11-02 Eli Lilly And Company Epimerization reaction for the production of r-fluoxetine
EP1687254A2 (de) 2004-06-28 2006-08-09 Teva Pharmaceutical Fine Chemicals S.R.L. Verfahren zur optischen trennung und rückgewinnung von tomoxetin
EP1768949A2 (de) 2004-07-22 2007-04-04 Teva Pharmaceutical Fine Chemicals S.R.L. Polymorphe von atomoxetien-hydrochlorid

Also Published As

Publication number Publication date
US20060009530A1 (en) 2006-01-12
DK1761478T3 (da) 2008-12-15
US7378553B2 (en) 2008-05-27
WO2006068662A1 (en) 2006-06-29
WO2006004923A2 (en) 2006-01-12
WO2006004976A2 (en) 2006-01-12
JP2008504302A (ja) 2008-02-14
US7317127B2 (en) 2008-01-08
EP1761478A2 (de) 2007-03-14
EP1682485A2 (de) 2006-07-26
US7439398B2 (en) 2008-10-21
US20060009531A1 (en) 2006-01-12
US7355078B2 (en) 2008-04-08
EP1687254A2 (de) 2006-08-09
IL180357A0 (en) 2007-06-03
CA2561866A1 (en) 2006-01-12
US20060009489A1 (en) 2006-01-12
PL1761478T3 (pl) 2009-04-30
IL180356A0 (en) 2007-06-03
IL180354A0 (en) 2007-06-03
WO2006004976A3 (en) 2006-02-16
KR20070057703A (ko) 2007-06-07
CA2560899A1 (en) 2006-01-12
CA2561015A1 (en) 2006-06-29
CA2561387A1 (en) 2006-01-12
US7507861B2 (en) 2009-03-24
ES2313387T3 (es) 2009-03-01
KR20070001250A (ko) 2007-01-03
WO2006004979A2 (en) 2006-01-12
EP1704138A1 (de) 2006-09-27
WO2006004923A3 (en) 2006-04-20
WO2006004977A3 (en) 2006-04-13
IL180353A0 (en) 2007-06-03
CA2561386A1 (en) 2006-01-12
EP1761478B1 (de) 2008-09-03
US20060009532A1 (en) 2006-01-12
WO2006004979A3 (en) 2006-04-13
US20060009490A1 (en) 2006-01-12
IL180355A0 (en) 2007-06-03
WO2006004977A2 (en) 2006-01-12

Similar Documents

Publication Publication Date Title
ATE407111T1 (de) Isolierte atomoxetinverunreinigung, verfahren zur herstellung von atomoxetinverunreinigungen und deren verwendung als referenzstandards
ATE443038T1 (de) Verfahren zur herstellung von cinacalcet hydrochlorid
ATE444950T1 (de) Verfahren zur herstellung von 1-amino-3,5- dimethyladamantan-hydrochlorid
ATE486857T1 (de) Verfahren zur herstellung von telmisartan
ATE423756T1 (de) Verfahren zur herstellung von hochreinem methyl- tert.-butylether
EA200900474A1 (ru) Способ получения мемантина и его гидрохлорида
ATE414707T1 (de) Verfahren zur herstellung von 4-amino-4'-demethyl-4-desoxypodophylotoxin
ATE447567T1 (de) Verfahren zur herstellung von tryptase- inhibitoren
UY29498A1 (es) Derivados de aminoácidos
ATE482188T1 (de) Verfahren zur synthese von 3-hydroxyglutaronitril
TW200738650A (en) Process for synthesis of aryloxy diaminopyrimidines
ATE346061T1 (de) Verfahren zur herstellung von (s)-3-methylamino-1-(thien-2-yl)propan-1-ol
ATE423096T1 (de) Verfahren zur herstellung von 2- azabicycloä3.3.0üoctan-3-carbonsäurederivaten
DE602004014290D1 (de) Verfahren zur herstellung von 2,3,5-trimethylhydrochinondiacylaten
ATE427297T1 (de) Verfahren zur herstellung von beta- aminopropionsaurederivaten
ATE416156T1 (de) Verfahren zur herstellung von acetessigsäurearylamiden
ATE415404T1 (de) Lösungsmittelfreies verfahren zur herstellung von diketopyrrolopyrrol-derivaten
ATE359287T1 (de) Ein verfahren zur herstellung von clopidogrel
DE502005009657D1 (de) Verfahren zur herstellung von substituierten thiophensulfonylisocyanaten
ATE380792T1 (de) Verfahren zur herstellung von pyrrolidinoximen
ATE370950T1 (de) Verfahren zur herstellung von (1s,4r)-cis-4-(2- amino-6-chlor-9h-purin-9-yl)-2-cyclopenten-1- methanol
NO20076307L (no) Fremgangsmater for a fremstille biarylurinstoffer og analoger derav
ATE403418T1 (de) Verfahren zur herstellung von festen dosierformen von amorphem valganciclovir-hydrochlorid
EA200601563A1 (ru) Водно-изопропанольный сольват оланзапина
ATE442351T1 (de) Verfahren zur herstellung von carbodiimidgruppen aufweisenden substanzen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1761478

Country of ref document: EP

REN Ceased due to non-payment of the annual fee